Created in 2004 by EuroScience, this biennial European forum brings together over 4,000 researchers, educators, business actors, policy makers and journalists from all over the world to
discuss breakthroughs in science.
Not exact matches
Recently, Emoryâ $ ™ s Jeff Koplan, MD, vice president for global health and past CDC director, participated
in a
Breakthroughs panel sponsored by Big Think, Pfizer and Discover to
discuss the latest issues
in pandemic and genomic
science, fields that have not only made big headlines recently but also promise to be two of the most pressing topics
in global
science and medicine
in coming years.
The ESOF 2018 event to be held
in Toulouse, 9 - 14 July 2018 will bring 4,500 leading thinkers, innovators, policy makers, journalists and educators from more than 90 countries, to
discuss current and future
breakthroughs in contemporary
science.
In discussing medical
breakthroughs, Morton Meyers makes a cogent, highly engaging argument for a more creative, rather than purely linear, approach to
science.
Apart from the fundamental scientific advances of the
breakthrough papers, there is an hierarchy of classes of lesser papers, along the lines of those which — • Confirm or deny the main thrust of a
breakthrough paper by arriving from other angles • Provide an alternative or improvement to the main findings of
breakthrough papers • Contribute more observation to the
breakthrough paper and
discuss its relevance • Seek to set a complementary base for a
breakthrough in a related aspect of
science • Report the views of a clutch of authors about a topic they deem to have political importance • Ditto for educational importance • Write papers that are knowingly lacking good
science to place authors
in one camp or another • Lambast an author or authors for being on the «wrong» side of a polarised topic • Perform meta analysis Etc..